Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Valeritas Holdings, Inc. (OTC: VLRX).

Full DD Report for VLRX

You must become a subscriber to view this report.


Recent News from (OTC: VLRX)

Valeritas Announces Positive Clinical Results Across Two New Studies Evaluating V-Go® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes
BRIDGEWATER, N.J., May 18, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers V-Go® Wearable Insulin Delivery device , a simple, all-in-one insulin delivery option for patients with diabetes, announced positive results were share...
Source: GlobeNewswire
Date: May, 18 2018 07:00
Free Post Earnings Research Report: Integra's Quarterly Sales Surged 38%; Adjusted EPS Soared 49%
Stock Monitor: Valeritas Holdings Post Earnings Reporting LONDON, UK / ACCESSWIRE / May 16, 2018 / If you want access to our free earnings report on Integra LifeSciences Holdings Corp. (NASDAQ: IART ) ("Integra"), all you need to do is sign up now by clicking the following link www....
Source: ACCESSWIRE IA
Date: May, 16 2018 07:50
Valeritas' V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes
BRIDGEWATER, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and ca...
Source: GlobeNewswire
Date: May, 14 2018 07:00
Valeritas' (VLRX) CEO John Timberlake on Q1 2018 Results - Earnings Call Transcript
Valeritas Holdings, Inc. (VLRX) Q1 2018 Results Earnings Conference Call May 09, 2018 04:30 PM ET Executives Greg Chodaczek - IR, Gilmartin Group John Timberlake - President and CEO Erick Lucera - CFO Analysts Ryan Blicker - Cowen Presentation Operator Good aftern...
Source: SeekingAlpha
Date: May, 09 2018 22:50
Valeritas misses by $0.06, beats on revenue
Valeritas (NASDAQ: VLRX ): Q1 EPS of -$1.72 misses by $0.06 . More news on: Valeritas Holdings, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 09 2018 16:39
Valeritas Reports Record First Quarter Revenue with 32% Year-over-Year Growth and Gross Margins Expand to Record 47.6%
BRIDGEWATER, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device , a simple, affordable, all-in-one insulin delivery option that is worn like a patch and ...
Source: GlobeNewswire
Date: May, 09 2018 16:01
Valeritas to Report First Quarter 2018 Results on May 9, 2018
BRIDGEWATER, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go ® Wearable Insulin Delivery device , a simple, affordable, all-in-one insulin delivery option that is worn like a patch an...
Source: GlobeNewswire
Date: May, 01 2018 07:00
Premarket Gainers as of 9:05 am (04/30/2018)
STDY +81%  on acquisition by United Therapeutics for up to $216M. More news on: SteadyMed, Pluristem Therapeutics, Inc., Andeavor, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 30 2018 09:27
Valeritas' V-Go wearable insulin delivery device shows treatment benefit in type 2 diabetics in real-world study; shares up 8% premarket
Thinly traded nano cap Valeritas Holdings (NASDAQ: VLRX ) is up  8%  premarket on increased volume in response to its announcement of positive data from a real-world, retrospective analysis of type 2 diabetics with poorly controlled A1C levels who switched from their current insu...
Source: SeekingAlpha
Date: April, 30 2018 08:14
Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets
BRIDGEWATER, N.J., April 30, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and ...
Source: GlobeNewswire
Date: April, 30 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-211.411.2871.42841.27266,773
2018-08-201.421.401.451.38232,345
2018-08-141.45271.42321.471.39178,411
2018-08-131.521.461.58721.40142,789
2018-08-101.611.511.611.46356,363

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2017-03-141,1001,45475.6534Short
2017-03-133,7004,30086.0465Short
2017-03-103,4003,90087.1795Short
2017-03-099005,10017.6471Cover
2017-02-071,0001,90052.6316Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VLRX.


About Valeritas Holdings, Inc. (OTC: VLRX)

Logo for Valeritas Holdings, Inc. (OTC: VLRX)

Valeritas is a commercial stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type diabetes. Valeritas flagship product, V Go Disposable Insulin Delivery device, is a simple, wearable, basal bolus insulin delivery solution for patients with Type diabetes that enables patients to administer a continuous preset basal rate of insulin over hours. It also provides on demand bolus dosing at mealtimes. It is the only basal bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R amp D functions in a state of the art facility in Shrewsbury, Massachusetts. For more information, please visit www.valeritas.com.

 

Contact Information

 

 

Current Management

  • John Timberlake / CEO, Chief Commercial Officer, President
  • Erick Lucera / CFO
  • Mark Conley / Vice President, Corporate Controller, Treasurer
  • Brian Johnston / IR Analyst
  • Rodney Altman / Independent Director
  • Katherine D. Crothall /
  • Peter Devlin / Independent Director
  • Luke Duster /
  • Joe Mandato /
  • Brian K Roberts /
  • John Timberlake /

Current Share Structure

  • Market Cap: $21,023,346 - 03/20/2018
  • Authorized: 300,000,000 - 06/30/2017
  • Issue and Outstanding: 7,007,782 - 02/26/2018

 


Recent Filings from (OTC: VLRX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Prospectus filed under Rule 424(b)(4)
Filing Type: 424B4Filing Source: edgar
Filing Date: April, 25 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: April, 23 2018
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Type: S-1MEFFiling Source: edgar
Filing Date: April, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 20 2018

 

 


Daily Technical Chart for (OTC: VLRX)

Daily Technical Chart for (OTC: VLRX)


Stay tuned for daily updates and more on (OTC: VLRX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: VLRX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VLRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of VLRX and does not buy, sell, or trade any shares of VLRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/